Novonesis Q1 Organic Sales Up 7%

Novonesis reported 7% organic sales growth in Q1, beating Jefferies consensus of 6.2%, aided by country exits and synergies.
Adjusted EBITDA rose to €423 million (up €10.2 m YoY) but margin slipped to 37.8% from 38.3% due to currency headwinds.
Adjusted net profit (ex‑PPA) grew 8% and free cash flow before acquisitions increased 9% to €74 million.
Company reaffirmed full‑year guidance of 5‑7% organic sales growth (≈1% from exits) and an adjusted EBITDA margin of 37‑38%.